Pneumocystis murina colonization in immunocompetent surfactant protein A deficient mice following environmental exposure

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Linke, Michael J ^a,b   Ashbaugh, Alan D ^b   Demland, Jeffery A ^b   Walzer, Peter D ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FUNGUS ANTIBODY; MESSENGER RNA; PNEUMOCYSTIS MURINA ANTIBODY; SURFACTANT PROTEIN A; UNCLASSIFIED DRUG; FUNGAL RNA; IMMUNOSUPPRESSIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE TRANSMISSION; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGAL COLONIZATION; GENE EXPRESSION; HOST SUSCEPTIBILITY; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENCE; LUNG ALVEOLUS CELL; LUNG INFECTION; MOUSE; NONHUMAN; PNEUMOCYSTIS; PNEUMOCYSTIS MURINA; PNEUMOCYSTIS MURINA INFECTION; PNEUMOCYSTOSIS; PROTEIN DEFICIENCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BLOOD; C3H MOUSE; DRUG EFFECT; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; LUNG; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PATHOGENICITY; PNEUMOCYSTIS PNEUMONIA; TIME;

ADRENAL CORTEX HORMONES; ANIMALS; ANTIBODIES, FUNGAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENVIRONMENTAL EXPOSURE; IMMUNITY, INNATE; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE AGENTS; LUNG; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; MICE, SCID; PNEUMOCYSTIS; PNEUMONIA, PNEUMOCYSTIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; RNA, FUNGAL; RNA, MESSENGER; TIME FACTORS;

EID: 65649141258     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-10     Document Type: Article

References (84)

1. Durand-Joly I, Aliouat E, Recourt C, Guyot K, Francois N, Wauquier M, Camus D, Dei-Cas E. Pneumocystis carinii f. sp. hominis is not infectious for SCID mice. J Clin Microbiol 2002, 40:1862-1865. 130940, 11980979, 10.1128/JCM.40.5.1862-1865.2002.
2. Arozullah AM, Yarnold PR, Weinstein RA, Nwadiaro N, McIlraith TB, Chmiel JS, Sipler AM, Chan C, Goetz MB, Schwartz DN, Bennett CL. A new preadmission staging system for predicting inpatient mortality from HIV-associated Pneumocystis carinii pneumonia in the early highly active antiretroviral therapy (HAART) era. Am J Respir Crit Care Med 2000, 161:1081-1086.
3. Nevez G, Totet A, Jounieaux V, Schmit JL, Dei-Cas E, Raccurt C. Pneumocystis jiroveci internal transcribed spacer types in patients colonized by the fungus and in patients with pneumocystosis from the same French geographic region. J Clin Microbiol 2003, 41:181-186. 149574, 12517845, 10.1128/JCM.41.1.181-186.2003.
4. Beard CB, Fox MR, Lawrence GG, Guarner J, Hanzlick RL, Huang L, Rio CD, Rimland D, Duchin JS, Colley DG. Genetic Differences in Pneumocystis Isolates Recovered from Immunocompetent Infants and from Adults with AIDS: Epidemiological Implications. J Infect Dis 2005, 192:1815-1818. 10.1086/497381, 16235182.
5. Vestereng VH, Bishop LR, Hernandez B, Kutty G, Larsen HH, Kovacs JA. Quantitative real-time polymerase chain-reaction assay allows characterization of Pneumocystis infection in immunocompetent mice. J Infect Dis 2004, 189:1540-1544. 10.1086/382486, 15073693.
6. Matos O, Costa MC, Lundgren B, Caldeira L, Aguiar P, Antunes F. Effect of oral washes on the diagnosis of Pneumocystis carinii pneumonia with a low parasite burden and on detection of organisms in subclinical infections. Eur J Clin Microbiol Infect Dis 2001, 20:573-575. 10.1007/s100960100563, 11681438.
7. Morris A, Kingsley LA, Groner G, Lebedeva IP, Beard CB, Norris KA. Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS 2004, 18:793-798. 10.1097/00002030-200403260-00011, 15075515.
8. Wakefield AE, Lindley AR, Ambrose HE, Denis CM, Miller RF. Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients. J Infect Dis 2003, 187:901-908. 10.1086/368165, 12660936.
9. Larsen HH, Masur H, Kovacs JA, Gill VJ, Silcott VA, Kogulan P, Maenza J, Smith M, Lucey DR, Fischer SH. Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia. J Clin Microbiol 2002, 40:490-494. 153364, 11825961, 10.1128/JCM.40.2.490-494.2002.
10. Norris KA, Morris A, Patil S, Fernandes E. Pneumocystis colonization, airway inflammation, and pulmonary function decline in acquired immunodeficiency syndrome. Immunol Res 2006, 36:175-187. 10.1385/IR:36:1:175, 17337778.
11. Morris A, Sciurba FC, Lebedeva IP, Githaiga A, Elliott WM, Hogg JC, Huang L, Norris KA. Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am J Respir Crit Care Med 2004, 170:408-413. 10.1164/rccm.200401-094OC, 15117741.
12. Calderon EJ, Rivero L, Respaldiza N, Morilla R, Montes-Cano MA, Friaza V, Munoz-Lobato F, Varela JM, Medrano FJ, Horra Cde L. Systemic inflammation in patients with chronic obstructive pulmonary disease who are colonized with Pneumocystis jiroveci. Clin Infect Dis 2007, 45:e17-e19. 10.1086/518989, 17578770.
13. Calderon E, de la Horra C, Medrano FJ, Lopez-Suarez A, Montes-Cano MA, Respaldiza N, Elvira-Gonzalez J, Martin-Juan J, Bascunana A, Varela JM. Pneumocystis jiroveci isolates with dihydropteroate synthase mutations in patients with chronic bronchitis. Eur J Clin Microbiol Infect Dis 2004, 23:545-549. 10.1007/s10096-004-1151-3, 15175932.
14. Walzer PD, Runck J, Steele P, White M, Linke MJ, Sidman CL. Immunodeficient and immunosuppressed mice as models to test anti-Pneumocystis carinii drugs. Antimicrob Agents Chemother 1997, 41:251-258. 163697, 9021175.
15. McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. Journal of Clinical Investigation 2002, 109:707-712. 150919, 11901176.
16. Korfhagen TR, Bruno MD, Ross GF, Huelsman KM, Ikegami M, Jobe AH, Wert SE, Stripp BR, Morris RE, Glasser SW, Bachurski CJ, Iwamoto HS, Whitsett JA. Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA 1996, 93:9594-9599. 38473, 8790375, 10.1073/pnas.93.18.9594.
17. LeVine AM, Whitsett JA. Pulmonary collectins and innate host defense of the lung. Microbes Infect 2001, 3:161-166. 10.1016/S1286-4579(00)01363-0, 11251302.
18. McCormack FX, Festa AL, Andrews RP, Linke M, Walzer PD. The carbohydrate recognition domain of surfactant protein A mediates binding to the major surface glycoprotein of Pneumocystis carinii. Biochemistry 1997, 36:8092-8099. 10.1021/bi970313f, 9201957.
19. Gaynor CD, McCormack FX, Voelker DR, McGowan SE, Schlesinger LS. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J Immunol 1995, 155:5343-5351.
20. Hickman-Davis JM, Fang FC, Nathan C, Shepherd VL, Voelker DR, Wright JR. Lung surfactant and reactive oxygen-nitrogen species: antimicrobial activity and host-pathogen interactions. Am J Physiol Lung Cell Mol Physiol 2001, 281:L517-L523.
21. Weissbach S, Neuendank A, Pettersson M, Schaberg T, Pison U. Surfactant protein A modulates release of reactive oxygen species from alveolar macrophages. Am J Physiol 1994, 267:L660-L666.
22. Wright JR, Youmans DC. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. Am J Physiol 1993, 264:L338-L344.
23. McCormack FX, Gibbons R, Ward SR, Kuzmenko A, Wu H, Deepe GSJ. Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem 2003, 278:36250-36256. 10.1074/jbc.M303086200, 12857753.
24. Linke MJ, Harris CE, Korfhagen TR, McCormack FX, Ashbaugh AD, Steele P, Whitsett JA, Walzer PD. Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection. J Infect Dis 2001, 183:943-952. 10.1086/319252, 11237812.
25. Linke M, Ashbaugh A, Koch J, Tanaka R, Walzer P. Surfactant protein A limits Pneumocystis murina infection in immunosuppressed C3H/HeN mice and modulates host response during infection. Microbes and Infection 2005, 7:748-759. 15857803 .
26. Atochina EN, Beck JM, Preston AM, Haczku A, Tomer Y, Scanlon ST, Fusaro T, Casey J, Hawgood S, Gow AJ, Beers MF. Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species. Infect Immun 2004, 72:6002-6011. 517574, 15385504, 10.1128/IAI.72.10.6002-6011.2004.
27. Korfhagen TR, LeVine AM, Whitsett JA. Surfactant protein A (SP-A) gene targeted mice. Biochim Biophys Acta 1998, 1408:296-302.
28. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher JH, Kim KS, McCormack FX. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 2003, 111:1589-1602. 155045, 12750409.
29. Shellito J, Suzara VV, Blumenfeld W, Beck JM, Steger HJ, Ermak TH. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest 1990, 85:1686-1693. 296622, 2139668, 10.1172/JCI114621.
30. McFadden DC, Powles MA, Pittarelli LA, Schmatz DM. Establishment of Pneumocystis carinii in various mouse strains using natural transmission to initiate infection. J Protozool 1991, 38:126S-127S.
31. Bartlett MS, Queener SF, Durkin MM, Shaw MA, Smith JW. Inoculated mouse model of Pneumocystis carinii infection. Diagn Microbiol Infect Dis 1992, 15:129-134. 10.1016/0732-8893(92)90036-S, 1572137.
32. Ruan S, Tate C, Lee JJ, Ritter T, Kolls JK, Shellito JE. Local delivery of the viral interleukin-10 gene suppresses tissue inflammation in murine Pneumocystis carinii infection. Infect Immun 2002, 70:6107-6113. 130425, 12379687, 10.1128/IAI.70.11.6107-6113.2002.
33. Steele C, Marrero L, Swain S, Harmsen AG, Zheng M, Brown GD, Gordon S, Shellito JE, Kolls JK. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor. J Exp Med 2003, 198:1677-1688. 2194130, 14657220, 10.1084/jem.20030932.
34. Linke M, Ashbaugh A, Demland J, Koch J, Tanaka R, Walzer P. Resolution of Pneumocystis murina infection following withdrawal of corticosteroid induced immunosuppression. Microb Pathog 2006, 40:15-22. 10.1016/j.micpath.2005.10.002, 16321497.
35. Thullen TD, Ashbaugh AD, Daly KR, Linke MJ, Steele PE, Walzer PD. New rat model of Pneumocystis pneumonia induced by anti-CD4(+) T-lymphocyte antibodies. Infect Immun 2003, 71:6292-6297. 219604, 14573648, 10.1128/IAI.71.11.6292-6297.2003.
36. Bartlett MS, Vermund SH, Jacobs R, Durant PJ, Shaw MM, Smith JW, Tang X, Lu JJ, Li B, Jin S, Lee CH. Detection of Pneumocystis carinii DNA in air samples: likely environmental risk to susceptible persons. J Clin Microbiol 1997, 35:2511-2513. 230001, 9316898.
37. Olsson M, Sukura A, Lindberg LA, Linder E. Detection of Pneumocystis carinii DNA by filtration of air. Scand J Infect Dis 1996, 28:279-282. 10.3109/00365549609027173, 8863362.
38. Wakefield AE. DNA sequences identical to Pneumocystis carinii f. sp. carinii and Pneumocystis carinii f. sp. hominis in samples of air spora. J Clin Microbiol 1996, 34:1754-1759. 229108, 8784583.
39. Maher N, Dillon HK, Vermund SH, Unnasch TR. Magnetic bead capture eliminates PCR inhibitors in samples collected from the airborne environment, permitting detection of Pneumocystis carinii DNA. Appl Environ Microbiol 2001, 67:449-452. 92598, 11133478, 10.1128/AEM.67.1.449-452.2001.
40. Vargas SL, Ponce CA, Gigliotti F, Ulloa AV, Prieto S, Munoz MP, Hughes WT. Transmission of Pneumocystis carinii DNA from a patient with P. carinii pneumonia to immunocompetent contact health care workers. J Clin Microbiol 2000, 38:1536-1538. 86483, 10747139.
41. Chave JP, David S, Wauters JP, van Melle G, Francioli P. Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients. AIDS 1991, 5:927-932. 10.1097/00002030-199108000-00002, 1777173.
42. Rabodonirina M, Vanhems P, Couray-Targe S, Gillibert RP, Ganne C, Nizard N, Colin C, Fabry J, Touraine JL, van Melle G, Nahimana A, Francioli P, Hauser PM. Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patients. Emerg Infect Dis 2004, 10:1766-1773.
43. Manoloff ES, Francioli P, Taffe P, van Melle G, Bille J, Hauser PM. Risk for Pneumocystis carinii transmission among patients with pneumonia: a molecular epidemiology study. Emerg Infect Dis 2003, 9:132-134.
44. Wohl AR, Simon P, Hu YW, Duchin JS. The role of person-to-person transmission in an epidemiologic study of Pneumocystis carinii pneumonia. AIDS 2002, 16:1821-1825. 10.1097/00002030-200209060-00016, 12218395.
45. Keely SP, Baughman RP, Smulian AG, Dohn MN, Stringer JR. Source of Pneumocystis carinii in recurrent episodes of pneumonia in AIDS patients. AIDS 1996, 10:881-888. 10.1097/00002030-199607000-00011, 8828745.
46. Latouche S, Poirot JL, Bernard C, Roux P. Study of internal transcribed spacer and mitochondrial large-subunit genes of Pneumocystis carinii hominis isolated by repeated bronchoalveolar lavage from human immunodeficiency virus-infected patients during one or several episodes of pneumonia. J Clin Microbiol 1997, 35:1687-1690. 229822, 9196174.
47. Wakefield AE, Pixley FJ, Banerji S, Sinclair K, Miller RF, Moxon ER, Hopkin JM. Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin. Mol Biochem Parasitol 1990, 43:69-76. 10.1016/0166-6851(90)90131-5, 1705311.
48. Peters SE, Wakefield AE, Sinclair K, Millard PR, Hopkin JM. A search for Pneumocystis carinii in post-mortem lungs by DNA amplification. J Pathol 1992, 166:195-8. 10.1002/path.1711660217, 1373186.
49. Leigh TR, Kangro HO, Gazzard BG, Jeffries DJ, Collins JV. DNA amplification by the polymerase chain reaction to detect sub-clinical Pneumocystis carinii colonization in HIV-positive and HIV-negative male homosexuals with and without respiratory symptoms. Respir Med 1993, 87:525-59. 10.1016/0954-6111(93)90008-N, 8265840.
50. Wakefield AE, Pixley FJ, Banerji S, Sinclair K, Miller RF, Moxon ER, Hopkin JM. Detection of Pneumocystis carinii with DNA amplification. Lancet 1990, 336:451-3. 10.1016/0140-6736(90)92008-6, 1974987.
51. Nevez G, Magois E, Duwat H, Gouilleux V, Jounieaux V, Totet A. Apparent absence of Pneumocystis jirovecii in healthy subjects. Clin Infect Dis 2006, 42:99-101.
52. Nevez G, Raccurt C, Jounieaux V, Dei-Cas E, Mazars E. Pneumocystosis versus pulmonary Pneumocystis carinii colonization in HIV-negative and HIV-positive patients. AIDS 1999, 13:535-56. 10.1097/00002030-199903110-00020, 10197390.
53. Davis JL, Welsh DA, Beard CB, Jones JL, Lawrence GG, Fox MR, Crothers K, Morris A, Charbonnet D, Swartzman A, Huang L. Pneumocystis colonisation is common among hospitalised HIV infected patients with non-Pneumocystis pneumonia. Thorax 2008, 63:329-34. 10.1136/thx.2007.088104, 18024536.
54. Sing A, Roggenkamp A, Autenrieth IB, Heesemann J. Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR. J Clin Microbiol 1999, 37:3409-3410. 85586, 10488221.
55. Varela JM, Dapena J, Regordan C, Blanco M, Gonzalez de la Puente MA, Calderon EJ. Absence of Pneumocystis carinii carriers among patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 1998, 17:741-2. 10.1007/s100960050174, 9865993.
56. Sing A, Geiger AM, Hogardt M, Heesemann J. Pneumocystis carinii carriage among cystic fibrosis patients, as detected by nested PCR. J Clin Microbiol 2001, 39:2717-2718. 88220, 11427604, 10.1128/JCM.39.7.2717-2718.2001.
57. Respaldiza N, Montes-Cano MA, Dapena FJ, de la Horra C, Mateos I, Medrano FJ, Calderon E, Varela JM. Prevalence of colonisation and genotypic characterisation of Pneumocystis jirovecii among cystic fibrosis patients in Spain. Clin Microbiol Infect 2005, 11:1012-1015. 10.1111/j.1469-0691.2005.01276.x, 16307556.
58. Montes-Cano MA, de la Horra C, Dapena FJ, Mateos I, Friaza V, Respaldiza N, Munoz-Lobato F, Medrano FJ, Calderon EJ, Varela JM. Dynamic colonisation by different Pneumocystis jirovecii genotypes in cystic fibrosis patients. Clin Microbiol Infect 2007, 13:1008-1011. 10.1111/j.1469-0691.2007.01789.x, 17711486.
59. Calderon EJ, Regordan C, Medrano FJ, Ollero M, Varela JM. Pneumocystis carinii infection in patients with chronic bronchial disease. Lancet 1996, 347:977. 10.1016/S0140-6736(96)91468-3, 8598795.
60. Chabe M, Dei-Cas E, Creusy C, Fleurisse L, Respaldiza N, Camus D, Durand-Joly I. Immunocompetent hosts as a reservoir of Pneumocystis organisms: histological and rt-PCR data demonstrate active replication. Eur J Clin Microbiol Infect Dis 2004, 23:89-97. 10.1007/s10096-003-1092-2, 14712369.
61. An CL, Gigliotti F, Harmsen AG. Exposure of immunocompetent adult mice to Pneumocystis carinii f. sp. muris by cohousing: growth of P. carinii f. sp. muris and host immune reresponse. Infect Immun 2003, 71:2065-2070. 152044, 12654827, 10.1128/IAI.71.4.2065-2070.2003.
62. Gigliotti F, Harmsen AG, Wright TW. Characterization of transmission of Pneumocystis carinii f. sp. muris through immunocompetent BALB/c mice. Infect Immun 2003, 71:3852-3856. 161994, 12819069, 10.1128/IAI.71.7.3852-3856.2003.
63. Keller LS, White WJ, Snider MT, Lang CM. An evaluation of intra-cage ventilation in three animal caging systems. Lab Anim Sci 1989, 39:237-242.
64. Icenhour CR, Rebholz SL, Collins MS, Cushion MT. Widespread occurrence of Pneumocystis carinii in commercial rat colonies detected using targeted PCR and oral swabs. J Clin Microbiol 2001, 39:3437-3441. 88368, 11574552, 10.1128/JCM.39.10.3437-3441.2001.
65. Walzer PD, Kim CK, Linke MJ, Pogue CL, Huerkamp MJ, Chrisp CE, Lerro AV, Wixson SK, Hall E, Shultz LD. Outbreaks of Pneumocystis carinii pneumonia in colonies of immunodeficient mice. Infect Immun 1989, 57:62-70. 313041, 2642471.
66. Myers DD, Smith E, Schweitzer I, Stockwell JD, Paigen BJ, Bates R, Palmer J, Smith AL. Assessing the risk of transmission of three infectious agents among mice housed in a negatively pressurized caging system. Contemp Top Lab Anim Sci 2003, 42:16-21.
67. Hanano R, Kaufmann SH. Pneumocystis carinii pneumonia in mutant mice deficient in both TCRα/β and TCRγ/δ cells: cytokine and antibody responses. J Infect Dis 1999, 179:455-459. 10.1086/314607, 9878031.
68. George CL, Goss KL, Meyerholz DK, Lamb FS, Snyder JM. Surfactant associated protein-A provides critical immunoprotection in neonatal mice. Infect Immun 2007, 2223658, 17967856.
69. Atochina EN, Gow AJ, Beck JM, Haczku A, Inch A, Kadire H, Tomer Y, Davis C, Preston AM, Poulain F, Hawgood S, Beers MF. Delayed clearance of Pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice. J Infect Dis 2004, 189:1528-1539. 10.1086/383130, 15073692.
70. Mason RJ, Greene K, Voelker DR. Surfactant protein A and surfactant protein D in health and disease. Am J Physiol 1998, 275:L1-13.
71. Koziel H, Phelps DS, Fishman JA, Armstrong MY, Richards FF, Rose RM. Surfactant protein-A reduces binding and phagocytosis of Pneumocystis carinii by human alveolar macrophages in vitro. Am J Respir Cell Mol Biol 1998, 18:834-843.
72. Williams MD, Wright JR, March KL, Martin WJ. Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages. Am J Respir Cell Mol Biol 1996, 14:232-238.
73. Brinker KG, Garner H, Wright JR. Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells. Am J Physiol Lung Cell Mol Physiol 2003, 284:L232-L241.
74. Brinker KG, Martin E, Borron P, Mostaghel E, Doyle C, Harding CV, Wright JR. Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells. Am J Physiol Lung Cell Mol Physiol 2001, 281:L1453-L1463.
75. Lin PM, Wright JR. Surfactant protein A binds to IgG and enhances phagocytosis of IgG-opsonized erythrocytes. Am J Physiol Lung Cell Mol Physiol 2006, 291:L1199-L1206. 10.1152/ajplung.00188.2006, 17090701.
76. Beharka AA, Gaynor CD, Kang BK, Voelker DR, McCormack FX, Schlesinger LS. Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J Immunol 2002, 169:3565-3573.
77. Lundgren B, Elvin K, Rothman LP, Ljungstrom I, Lidman C, Lundgren JD. Transmission of Pneumocystis carinii from patients to hospital staff. Thorax 1997, 52:422-424. 1758557, 9176532.
78. Sternberg RI, Whitsett JA, Hull WM, Baughman RP. Pneumocystis carinii alters surfactant protein A concentrations in bronchoalveolar lavage fluid. J Lab Clin Med 1995, 125:462-469.
79. Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical significance of pneumocystis colonization. J Infect Dis 2008, 197:10-7. 10.1086/523814, 18171279.
80. Tagaram HR, Wang G, Umstead TM, Mikerov AN, Thomas NJ, Graff GR, Hess JC, Thomassen MJ, Kavuru MS, Phelps DS, Floros J. Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health. Am J Physiol Lung Cell Mol Physiol 2007, 292:L1052-63. 10.1152/ajplung.00249.2006, 17189324.
81. Christensen PJ, Preston AM, Ling T, Du M, Fields WB, Curtis JL, Beck JM. Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice. Infect Immun 2008, 76:3481-90. 2493196, 18490462, 10.1128/IAI.00165-08.
82. Sorensen GL, Husby S, Holmskov U. Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 416(212):381-416.
83. Mikerov AN, Umstead TM, Huang W, Liu W, Phelps DS, Floros J. SP-A1 and SP-A2 variants differentially enhance association of Pseudomonas aeruginosa with rat alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2005, 288:L150-8. 10.1152/ajplung.00135.2004, 15377498.
84. Wang G, Bates-Kenney SR, Tao JQ, Phelps DS, Floros J. Differences in biochemical properties and in biological function between human SP-A1 and SP-A2 variants, and the impact of ozone-induced oxidation. Biochemistry 2004, 43:4227-439. 10.1021/bi036023i, 15065867.